2015
DOI: 10.1128/jcm.01547-15
|View full text |Cite
|
Sign up to set email alerts
|

Performance of the CLSI Carba NP and the Rosco Carb Screen Assays Using North American Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa Isolates

Abstract: fThis study compared the performance of the Carba NP assay, published by the Clinical and Laboratory Standards Institute, and the Rosco Rapid Carb Screen kit. Carba NP had superior sensitivity, but both assays required an increased inoculum to detect carbapenemase production in isolates with bla NDM , bla IMP , and bla OXA-48 . Rapid detection of carbapenemase production in multidrugresistant organisms may help to mitigate institutional outbreaks by expediting initiation of infection control procedures (1). No… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
12
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 10 publications
2
12
0
Order By: Relevance
“…At least two reasons might have accounted for those differences. First, the distribution of carbapenemase types among CPE isolates comprised a larger proportion of OXA-48 producers (62.2%) that are known to be less well detected by these two assays (8,10,12,14). However, this high proportion of OXA-48 producers is in line with the current epidemiology of CPE observed in several European countries such as Belgium, France, Spain, or Germany (4).…”
Section: Discussionmentioning
confidence: 54%
See 1 more Smart Citation
“…At least two reasons might have accounted for those differences. First, the distribution of carbapenemase types among CPE isolates comprised a larger proportion of OXA-48 producers (62.2%) that are known to be less well detected by these two assays (8,10,12,14). However, this high proportion of OXA-48 producers is in line with the current epidemiology of CPE observed in several European countries such as Belgium, France, Spain, or Germany (4).…”
Section: Discussionmentioning
confidence: 54%
“…The Neo-Rapid Carb kit and the Rapidec Carba NP test have been evaluated by several groups (8)(9)(10)(11)(12)(13)(14)(15)(16), but, to our knowledge, no comparison with the novel ␤ Carba test has been published yet. Evaluations of the colorimetric carbapenem hydrolysis assays have mostly focused on Enterobacteriaceae, while reports dealing with nonfermentative Gram-negative bacilli are scarce.…”
mentioning
confidence: 99%
“…Nordmann and coworkers described a new inhibitor-based biochemical assay for carbapenemase detection, the Carba NP test, which has been developed in two versions; the Carba NP-I assay provides a positive or negative result (carbapenemase detected or not detected), whereas the Carba NP-II test is designed to discriminate among carbapenemase classes A, B, and D (17,18). Two commercially available tests use the principle of imipenem hydrolysis and a colorimetric pH indicator to detect the presence of carbapenemases, i.e., the Rapid Carb Screen kit (Rosco Diagnostica, Taastrup, Denmark) and the Rapidec Carba NP test, which was derived from the Carba NP-I assay and was introduced recently into the market (19,20). The Rapid Carb Screen kit contains three separate vials, whereas the Rapidec Carba NP is performed on one plastic strip with preformed wells, which limits handling and minimizes the potential for confusion of the vials.…”
mentioning
confidence: 99%
“…In principle, the test is similar to the classic ␤-lactamase detection assays described by Escamilla and by Skinner and Wise in the 1970s, in which benzylpenicillin acidimetrically produced a red color after hydrolysis by Haemophilus influenzae ␤-lactamase (1, 2). With the Carba NP test, hydrolysis of imipenem produces acid and drives the pH indicator, phenol red, from red to yellow.The Carba NP test has been studied by several investigators (3-14), including evaluations and comparisons to a commercial version (15)(16)(17)(18)(19)(20). However, the literature lacks consistency in the Carba NP methodology.…”
mentioning
confidence: 99%
“…The Carba NP test has been studied by several investigators (3-14), including evaluations and comparisons to a commercial version (15)(16)(17)(18)(19)(20). However, the literature lacks consistency in the Carba NP methodology.…”
mentioning
confidence: 99%